Woodline Partners LP Sera Prognostics, Inc. Transaction History

Woodline Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.2 - $3.62 $82,914 - $250,123	-69,095 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.96 - $8.8 $174,785 - $519,631	-59,049 Reduced 46.08%	69,095 $262,000
Q4 2021 Feb 14, 2022	SELL	$6.87 - $11.41 $420,224 - $697,926	-61,168 Reduced 32.31%	128,144 $880,000
Q3 2021 Nov 15, 2021	BUY	$7.9 - $13.04 $1.5 Million - $2.47 Million	189,312 New	189,312 $2.1 Million

20.3M

120K

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $201M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.